Neurology· Topic 10.8 Central nervous system infections· 10.8.4

Cryptococcal meningoencephalitis

Cryptococcal meningoencephalitis is the most common cause of fungal meningitis worldwide, driven by CNS dissemination of inhaled Cryptococcus in an immunosuppressed host, typically HIV with a CD4 count under 50; treatment is induction amphotericin B plus flucytosine, consolidation and maintenance fluconazole, and aggressive lowering of elevated intracranial pressure.

12 min read17 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    The most common cause of fungal meningitis worldwide: cryptococcal meningoencephalitis results from central nervous system dissemination of Cryptococcus, an encapsulated yeast that is ubiquitous in the environment.

  • Epidemiology

    The most common manifestation of C. neoformans disease in human immunodeficiency virus (HIV)-infected patients, usually occurring when the helper T-cell (CD4) count is less than 50/microliter.

  • Risk factors

    HIV infection with a CD4 cell count under 50/microliter: the dominant risk factor and the population in whom disease is most severe.

  • Pathophysiology

    Inhalation of aerosolized Cryptococcus spores into the respiratory tract is the initial event, producing asymptomatic or mild pulmonary infection in most exposed persons.

  • Clinical features

    Insidious onset over days to weeks: fever, headache, and malaise with a waxing and waning course, unlike the acute onset of bacterial meningitis.

  • Differential diagnosis

    Tuberculous meningitis: a subacute course with CSF lymphocytic pleocytosis, elevated protein, and low glucose overlapping cryptococcal meningitis, but acid-fast smear is insensitive and culture…

  • Diagnosis

    Cryptococcal meningoencephalitis is confirmed by a positive CSF fungal culture (the gold standard) or a positive CSF cryptococcal antigen test, which has a sensitivity of 93% to 99%; severity and…

  • Management

    First, start induction antifungal therapy immediately for at least 2 weeks, which is effective in more than 90% of patients; extend induction to 4-6 weeks total in non-HIV, non-transplant patients or…

  • Complications

    Sudden blindness, deafness, or coma from uncontrolled elevated intracranial pressure: the principal driver of morbidity and the reason opening pressure must be documented and treated at every lumbar puncture.

  • Prognosis

    Adverse prognostic factors identified at diagnosis include altered mental status, visual abnormalities, a CSF leukocyte count under 20/microliter, a CSF cryptococcal antigen titer greater than…

  • Prevention

    No vaccine exists against Cryptococcus; prevention centers on maintaining immune competence and prompt treatment of at-risk hosts.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.